Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lexiscan Launch Gains CV Therapeutics $10M Milestone

Jun 24 2008

• By Shirley Haley

Related Content

CVT gets $175M For Half Of Lexiscan Royalties

Apr 15 2008

FDA Clears Astellas’ Lexiscan For Market

Apr 11 2008

EU Clears Ranolazine As CVT Bids For Broader U.S. Label

Apr 25 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window